To provide capital growth and income.
Name | % Net Assets |
---|---|
Vodafone Group PLC | 6.7% |
GlaxoSmithKline PLC | 6.6% |
Royal Dutch Shell PLC (CL B) | 6.0% |
BP PLC | 5.1% |
British American Tobacco PLC | 4.9% |
AstraZeneca PLC | 4.7% |
Imperial Tobacco Group PLC | 4.4% |
National Grid PLC | 4.3% |
BG Group PLC | 4.2% |
HSBC Holdings PLC | 3.7% |
Key | % Net Assets |
---|---|
Vodafone Group PLC | 6.7% |
GlaxoSmithKline PLC | 6.6% |
Royal Dutch Shell PLC (CL B) | 6.0% |
BP PLC | 5.1% |
Other | 75.6% |
Date | n/a |
---|---|
Bid | 0.00 |
Offer | 0.00 |
Currency | n/a |
Change | 0.00 |
% | n/a |
YTD change | 0.00 |
YTD % | n/a |
Fund Inception | 13/02/2004 |
---|---|
Fund Manager | n/a |
TER | - |
Minimum Investment | |
---|---|
Initial | 500000 |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 2.00% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.01 |
Sharpe ratio | 0.06 |
You are here: research